FDG-PET/CT in advanced ovarian cancer staging: Value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy

European Journal of Radiology

Volumn 80, Issue 2, 2011, Pages

  De Iaco, Pierandrea ^a   Musto, Alessandra ^a   Orazi, Luca ^a   Zamagni, Claudio ^a   Rosati, Marta ^a   Allegri, Vincenzo ^a   Cacciari, Nicoletta ^a   Al Nahhas, Adil ^b   Rubello, Domenico ^c   Venturoli, Stefano ^a   Fanti, Stefano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

Advanced ovarian cancer; FDG PET CT; Laparoscopy; Patient management; Staging

Indexed keywords

FLUORODEOXYGLUCOSE; PLATINUM; TAXANE DERIVATIVE;

ABDOMEN; ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GENERAL ANESTHESIA; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LAPAROSCOPY; OVARY CARCINOMA; PELVIS; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; DIAGNOSIS, DIFFERENTIAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LAPAROSCOPY; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 80053639489     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.07.013     Document Type: Article

References (30)

1. D.M. Parkin, P. Pisani, and J. Ferlay Estimates of the worldwide incidence of 25 major cancers in 1990 Int J Cancer 80 1999 827 841 (Pubitemid 29108856)
2. S. Pecorelli, F. Odicino, and P. Maisonneuve Carcinoma of the ovary J Epidemiol Biostat 3 1998 75 102
3. T.W. Park, and W.C. Kuhn Neoadjuvant chemotherapy in ovarian cancer Expert Rev Anticancer Ther 4 4 2004 639 647
4. R.E. Bristow, R.S. Tomacruz, D.K. Armstrong, E.L. Trimble, and F.J. Montz Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 20 2002 1248 1259 (Pubitemid 34177431)
5. W. Kuhn, G. Florack, and J. Roder The influence of upper abdominal surgery on perioperative morbidity and mortality in patients with advanced ovarian carcinoma FIGO III and FIGO IV Int J Gynecol Cancer 8 1998 56 63 (Pubitemid 28119959)
6. R. Naik, A. Nordin, P.A. Cross, D. Hemming, A. de Barros Lopes, and J.M. Monaghan Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelian ovarian cancer with hepatic metastases Gynecol Oncol 78 2000 171 175 (Pubitemid 30650349)
7. A.P. Heinz, N.F. Hacker, and J.S. Berek Cytoreductive surgery in ovarian carcinoma: feasibility ad morbidity Obstet Gynecol 67 1986 783 788 (Pubitemid 16060038)
8. S. Fanti, C. Nanni, and P. Castellucci Supra-clavicular lymph node metastatic spread in patients with ovarian cancer disclosed a 18F-FDG-PET/CT: an unusual finding Cancer Imaging 23 2006 20 23
9. G. Cormio, C. Rossi, and A. Cazzolla Distant metastases in ovarian carcinoma Int J Gynecol Cancer 13 2003 125 129 (Pubitemid 37055465)
10. R.Y. Zang, Z.Y. Zhang, S.M. Cai, M.Q. Tang, J. Chen, and Z.T. Li Epithelial ovarian cancer presenting initially with extraabdominal or intrahepatic metastases: a preliminary report of 25 cases and literature review Am J Clin Oncol 23 2000 416 419 (Pubitemid 32429158)
11. J.L. Brun, R. Rouzier, S. Uzan, and E. Daraï External validation of laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score Gynecol Oncol 110 2008 354 359
12. A. Fagotti, F. Fanfani, and C. Rossitto A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy Oncology 75 2008 152 158
13. S. Risum, C. Høgdall, and A. Loft The diagnostic value of PET/CT for primary ovarian cancer - a prospective study Gynecol Oncol 105 2007 145 149 (Pubitemid 46454333)
14. P. Castellucci, A.M. Perrone, and M. Picchio Diagnostic accuracy of 18F-FDG-PET/CT in the evaluation of adnexal masses and in staging ovarian cancer: correlation between histology, TVUS and c.e.CT Nucl Med Commun 28 8 2007 589 595 (Pubitemid 47067045)
15. C.M.C. Tempany, K.H. Zou, and G.S. Silverman Staging of advanced ovarian cancer: comparison of imaging modalities - Report from the Radiological Diagnostic Oncology Group Radiology 215 2000 761 767 (Pubitemid 30346013)
16. E. Tsukamoto, and S. Ochi PET/TC today: system and its impact on cancer diagnosis Ann Nucl Med 20 4 2006 255 267 (Pubitemid 44033266)
17. S.S. Gambhir Molecular imaging of cancer with positron emission tomography Nat Rev Cancer 2 2002 683 693 (Pubitemid 37328919)
18. K. Endo, N. Oriuchi, and T. Higuchi PET and PET/CT using 18F FDG in the diagnosis and management of cancer patients Int J Clin Oncol 11 4 2006 286 296 (Pubitemid 44306212)
19. D.W. Townsend, and T. Beyer A combined PET/CT scanner: the path to true image fusion Br J Radiol 75 2002 s24 s30
20. N. Subhas, P.V. Patel, H.K. Pannu, H.A. Jacene, E.K. Fisman, and R. Whal Imaging of pelvic malignancies with FDG PET-CT: case examples and common pitfalls of FDG PET Radiographics 25 4 2005 1031 1043 (Pubitemid 41196938)
21. H.J. Vesselle, and F.D. Miraldi FDG PET of the retro-peritoneum: normal anatomy, variants, pathologic conditions and strategies to avoid diagnostic pitfalls Radiographics 18 1998 805 823 (Pubitemid 128466690)
22. O. Drieskens, S. Stroobants, M. Gysen, G. Vandenbosch, L. Montelmans, and I. Vergote Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer Gynecol Obstet Invest 55 3 2003 130 134 (Pubitemid 36928630)
23. P.H. Sugarbaker Management of peritoneal-surface malignancy: the surgeon's role Langenbeck Arch Surg 384 1999 576 587 (Pubitemid 30020346)
24. S. Aebi, and M. Castiglione Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 4 2009 iv21 iv23
25. R.E. Scully Histological typing of ovarian tumours World Health Organization - International Classification of Tumours 2nd ed. 1999 Springer New York pp. 4-9
26. P. Castellucci, A.M. Perrone, and M. Picchio Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology Nucl Med Commun 28 2007 589 595 (Pubitemid 47067045)
27. E.J. Nam, M.J. Yun, and Y.T. Oh Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI Gynecol Oncol 2009 10.1016/j.ygyno.2009.10.059
28. S. Risum, C. Høgdall, and A. Loft The diagnostic value of PET/CT for primary ovarian cancer - a prospective study Gynecol Oncol 105 2007 5 149
29. L. Funicelli, L.L. Travaini, F. Landoni, G. Trifir, L. Bonello, and M. Bellomi Peritoneal carcinomatosis from ovarian cancer: the role of CT and [18F]FDG-PET/CT Abdom Imaging 2009 10.1007/s00261-009-9578-8
30. A. Turlakov Peritoneal carcinomatosis: role of 18F-FDG PET J Nucl Med 44 2003 1407 1412